These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15311969)

  • 21. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
    York D; Withers SS; Watson KD; Seo KW; Rebhun RB
    Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
    Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
    In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation induction of canine osteosarcoma cell lines by retinoids.
    Hong SH; Mochizuki M; Nishimura R; Sasaki N; Kadosawa T; Matsunaga S
    Res Vet Sci; 2000 Feb; 68(1):57-62. PubMed ID: 10684759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
    Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
    Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy.
    Inkol JM; Poon AC; Mutsaers AJ
    Vet Comp Oncol; 2020 Dec; 18(4):559-569. PubMed ID: 32060984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
    Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
    Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells.
    Duckett MM; Phung SK; Nguyen L; Khammanivong A; Dickerson E; Dusenbery K; Lawrence J
    Vet Comp Oncol; 2020 Mar; 18(1):128-140. PubMed ID: 31778284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines.
    Barroga EF; Kadosawa T; Okumura M; Fujinaga T
    Res Vet Sci; 1999 Jun; 66(3):231-6. PubMed ID: 10333464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.
    Sottnik JL; Hansen RJ; Gustafson DL; Dow SW; Thamm DH
    Vet Comp Oncol; 2011 Jun; 9(2):118-30. PubMed ID: 21569197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 20 alpha-hydroxysteroid dehydrogenase and its inhibitors on canine osteosarcoma cell growth in vitro.
    Tanaka NM; Shiota K; Noda K; Kadosawa T; Mochizuki M; Nishimura R; Takahashi M; Sasaki N
    J Vet Med Sci; 1996 Jul; 58(7):623-7. PubMed ID: 8844597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
    Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
    Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines.
    Kisseberth WC; Murahari S; London CA; Kulp SK; Chen CS
    Am J Vet Res; 2008 Jul; 69(7):938-45. PubMed ID: 18593248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.
    Patatsos K; Shekhar TM; Hawkins CJ
    Vet Comp Oncol; 2018 Dec; 16(4):544-553. PubMed ID: 29998615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
    Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
    Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seeking enrolment for a new treatment for canine osteosarcoma.
    Polton G; Dunning M
    J Small Anim Pract; 2015 Jul; 56(7):481. PubMed ID: 26134604
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of the potassium-sparing diuretic amiloride on chemotherapy response in canine osteosarcoma cells.
    Poon AC; Inkol JM; Luu AK; Mutsaers AJ
    J Vet Intern Med; 2019 Mar; 33(2):800-811. PubMed ID: 30556178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low concentrations of alendronate increase the local invasive potential of osteoblastic sarcoma cell lines via connexin 43 activation.
    Yoshitani K; Kido A; Honoki K; Akahane M; Fujii H; Tanaka Y
    Pathol Res Pract; 2011 Jul; 207(7):417-22. PubMed ID: 21665377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of canine osteosarcoma for limb preservation using osteotomy, adjuvant radiotherapy and chemotherapy (a case report).
    Theilen GH; Leighton R; Pool R; Park RD
    Vet Med Small Anim Clin; 1977 Feb; 72(2):179-83. PubMed ID: 265130
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of timing of bisphosphonate administration on canine osteosarcoma cells undergoing radiation therapy.
    Hoddinott K; Oblak ML; Wood GA; Boston S; Mutsaers AJ
    Can J Vet Res; 2020 Jul; 84(3):225-229. PubMed ID: 32801458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic action of Brazilian propolis in vitro on canine osteosarcoma cells.
    Cinegaglia NC; Bersano PR; Búfalo MC; Sforcin JM
    Phytother Res; 2013 Sep; 27(9):1277-81. PubMed ID: 23074147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.